SPRC Scisparc: neurothera Labs announces initiation of phase iib clinical trial at hannover Medical school in Germany for innovative treatme
SPRC Scisparc: neurothera Labs announces initiation of phase iib clinical trial at hannover Medical school in Germany for innovative treatment of tourette syndrome
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.